• Info
  • Insider Ownership

Insider Trading & Ownership of Rene Russo

Location
Waltham, MA
Summary
The estimated net worth of Rene Russo is at least $8,214,278 dollars as of 05 Jan 2026. Rene Russo is the Director of Adagio Therapeutics, Inc. and owns shares of Invivyd, Inc. (IVVD) stock worth about $7.84M. Rene Russo is the PRESIDENT AND CEO, Director of Xilio Therapeutics, Inc. and owns shares of Xilio Therapeutics, Inc. (XLO) stock worth about $372.4K.
Signature
/s/ Kevin Brennan, Attorney-in-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Rene Russo and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.

Sign up to save research and follow filings

Quick Takeaways

  • Rene Russo has 3 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $8,214,278.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Adagio Therapeutics, Inc. ($7,841,915).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Rene Russo

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
IVVD Adagio Therapeutics, Inc. Director $7,841,915 05 Aug 2021
XLO Xilio Therapeutics, Inc. PRESIDENT AND CEO, Director $372,363 +$24,680 +7.1% 31 Dec 2025
XFOR X4 Pharmaceuticals, Inc Director 02 Jun 2021

Insider Transactions Reported by Rene Russo:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.